{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:12:17Z","timestamp":1787883137924,"version":"build-2784847793"},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.kint.2019.07.026","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T11:17:54Z","timestamp":1567163874000},"page":"1346-1358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in\u00a0a\u00a0mouse model of chronic kidney disease"],"prefix":"10.1016","volume":"96","author":[{"given":"Connor","family":"Francis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Courbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Neuburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Dussold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maralee","family":"Capella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Isakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupal","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9527-2364","authenticated-orcid":false,"given":"Valentin","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2019.07.026_bib1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","article-title":"FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa","volume":"314","author":"Shimada","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.kint.2019.07.026_bib2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.07.026_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-nutr-071816-064620","article-title":"FGF23 and nutritional metabolism","volume":"37","author":"Pool","year":"2017","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.kint.2019.07.026_bib4","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.07.026_bib5","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2019.07.026_bib6","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1093\/ndt\/gfq309","article-title":"FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment","volume":"25","author":"Seiler","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2019.07.026_bib7","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","article-title":"Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality","volume":"22","author":"Wolf","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.07.026_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ki.2012.327","article-title":"Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community","volume":"83","author":"Arnlov","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.07.026_bib9","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.2215\/CJN.01880213","article-title":"Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation","volume":"8","author":"Baia","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.07.026_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00467-012-2336-0","article-title":"Beyond mineral metabolism, is there an interplay between FGF23 and vitamin D in innate immunity?","volume":"28","author":"Bacchetta","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2019.07.026_bib11","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2019.07.026_bib12","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.kint.2019.07.026_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41413-019-0051-1","article-title":"DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease","volume":"7","author":"Dussold","year":"2019","journal-title":"Bone Res"},{"key":"10.1016\/j.kint.2019.07.026_bib14","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1172\/JCI83470","article-title":"FGF23 signaling impairs neutrophil recruitment and host defense during CKD","volume":"126","author":"Rossaint","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2019.07.026_bib15","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","article-title":"Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease","volume":"90","author":"Singh","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.07.026_bib16","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2019.07.026_bib17","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1681\/ASN.2015020117","article-title":"Rationale and approaches to phosphate and fibroblast growth factor 23 reduction in CKD","volume":"26","author":"Isakova","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.07.026_bib18","first-page":"1096","article-title":"Effects of nicotinamide and lanthanum carbonate on serum phosphate and fibroblast growth factor-23 in CKD: the COMBINE trial","volume":"30","author":"Ix","year":"2019"},{"key":"10.1016\/j.kint.2019.07.026_bib19","first-page":"S11","article-title":"KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease","volume":"47","author":"Foundation","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2019.07.026_bib20","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1210\/jc.2011-1239","article-title":"Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans","volume":"96","author":"Imel","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2019.07.026_bib21","doi-asserted-by":"crossref","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","article-title":"Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice","volume":"108","author":"Farrow","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2019.07.026_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jbmr.2049","article-title":"Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice","volume":"29","author":"Clinkenbeard","year":"2014","journal-title":"J\u00a0Bone Mineral Res"},{"key":"10.1016\/j.kint.2019.07.026_bib23","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1210\/jc.2012-1811","article-title":"Biological variability of plasma intact and C-terminal FGF23 measurements","volume":"97","author":"Smith","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2019.07.026_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2015.290","article-title":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production","volume":"89","author":"David","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.07.026_bib25","doi-asserted-by":"crossref","first-page":"F1369","DOI":"10.1152\/ajprenal.00281.2016","article-title":"Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice","volume":"311","author":"Hanudel","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2019.07.026_bib26","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.3324\/haematol.2017.167882","article-title":"Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow","volume":"102","author":"Clinkenbeard","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.kint.2019.07.026_bib27","doi-asserted-by":"crossref","first-page":"F132","DOI":"10.1152\/ajprenal.00081.2017","article-title":"Acute blood loss stimulates fibroblast growth factor 23 production","volume":"314","author":"Rabadi","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2019.07.026_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2215\/CJN.05170513","article-title":"Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD","volume":"9","author":"Yokoyama","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.07.026_bib29","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.ajkd.2014.10.014","article-title":"A\u00a012-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5","volume":"65","author":"Block","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2019.07.026_bib30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000440968","article-title":"Administration of ferric citrate hydrate decreases circulating FGF23 levels independently of serum phosphate levels in hemodialysis patients with iron deficiency","volume":"131","author":"Iguchi","year":"2015","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2019.07.026_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jbmr.516","article-title":"Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease","volume":"27","author":"Stubbs","year":"2012","journal-title":"J\u00a0Bone Mineral Res"},{"key":"10.1016\/j.kint.2019.07.026_bib32","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ki.2012.222","article-title":"Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites","volume":"82","author":"Dai","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.07.026_bib33","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/ndt\/gfx332","article-title":"Genetic background influences cardiac phenotype in murine chronic kidney disease","volume":"33","author":"Neuburg","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2019.07.026_bib34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.07.026_bib35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0272-6386(99)70118-6","article-title":"Left ventricular mass index increase in early renal disease:impact of decline in hemoglobin","volume":"34","author":"Levin","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2019.07.026_bib36","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2019.07.026_bib37","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/nep.13495","article-title":"The hepcidin-25\/erythroferrone ratio predicts improvement of anemia in hemodialysis patients treated with ferric citrate hydrate","volume":"24","author":"Hara","year":"2019","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.kint.2019.07.026_bib38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10157-017-1510-x","article-title":"Effect of ferric citrate hydrate on FGF23 and PTH levels in patients with non-dialysis-dependent chronic kidney disease with normophosphatemia and iron deficiency","volume":"22","author":"Iguchi","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.kint.2019.07.026_bib39","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000489964","article-title":"Ferric citrate decreases fibroblast growth factor 23 and improves erythropoietin responsiveness in hemodialysis patients","volume":"47","author":"Maruyama","year":"2018","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2019.07.026_bib40","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.amjcard.2018.04.062","article-title":"Usefulness of oral ferric citrate in patients with iron-deficiency anemia and chronic kidney disease with or without heart failure","volume":"122","author":"McCullough","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.kint.2019.07.026_bib41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMra1004967","article-title":"Iron overload in human disease","volume":"366","author":"Fleming","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.07.026_bib42","doi-asserted-by":"crossref","unstructured":"Min HK, Sung SA, Oh YK, et\u00a0al. Hepcidin, iron indices and bone mineral metabolism in non-dialysis chronic kidney disease [e-pub ahead of print]. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfy235. Accessed September 4,\u00a02019.","DOI":"10.1093\/ndt\/gfy235"},{"key":"10.1016\/j.kint.2019.07.026_bib43","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1681\/ASN.2014080842","article-title":"Ferric citrate reduces intravenous iron and erythropoiesis-stimulating agent use in ESRD","volume":"26","author":"Umanath","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.07.026_bib44","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","article-title":"Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women","volume":"21","author":"Burnett","year":"2006","journal-title":"J\u00a0Bone Mineral Res"},{"key":"10.1016\/j.kint.2019.07.026_bib45","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1681\/ASN.2009050559","article-title":"Intestinal npt2b plays a major role in phosphate absorption and homeostasis","volume":"20","author":"Sabbagh","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.07.026_bib46","doi-asserted-by":"crossref","first-page":"13701","DOI":"10.1038\/s41598-018-32065-2","article-title":"Increased phosphaturia accelerates the decline in renal function: a search for mechanisms","volume":"8","author":"Santamaria","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2019.07.026_bib47","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1038\/s41598-017-02709-w","article-title":"FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts","volume":"7","author":"Smith","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2019.07.026_bib48","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1210\/en.2005-0670","article-title":"Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23","volume":"146","author":"Yu","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.kint.2019.07.026_bib49","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1152\/ajpendo.00596.2012","article-title":"FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy","volume":"304","author":"Touchberry","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.kint.2019.07.026_bib50","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/jcb.22842","article-title":"Both FGF23 and extracellular phosphate activate Raf\/MEK\/ERK pathway via FGF receptors in HEK293 cells","volume":"111","author":"Yamazaki","year":"2010","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.kint.2019.07.026_bib51","first-page":"41","article-title":"The management of left ventricular systolic dysfunction in patients with advanced chronic kidney disease","volume":"24","author":"Dounaevskaia","year":"2011","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.kint.2019.07.026_bib52","article-title":"Selective inhibition of the master regulator transcription factor Egr-1 with catalytic oligonucleotides reduces myocardial injury and improves left ventricular systolic function in a preclinical model of myocardial infarction","volume":"2","author":"Rayner","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.kint.2019.07.026_bib53","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0735-1097(00)00613-6","article-title":"The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations","volume":"35","author":"Silverberg","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2019.07.026_bib54","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ejhf.229","article-title":"The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study","volume":"17","author":"Ponikowski","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.kint.2019.07.026_bib55","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cbpa.2006.09.014","article-title":"Metabolic and genetic regulation of cardiac energy substrate preference","volume":"146","author":"Kodde","year":"2007","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"10.1016\/j.kint.2019.07.026_bib56","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1210\/en.2013-1627","article-title":"Calcium regulates FGF-23 expression in bone","volume":"154","author":"David","year":"2013","journal-title":"Endocrinology"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253819308427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253819308427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:54:43Z","timestamp":1758761683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253819308427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0085253819308427"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2019.07.026","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in\u00a0a\u00a0mouse model of chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2019.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}